Anzen Health’s “855-How-To-Quit-(Opioids)” campaign presents a novel approach to addressing the opioid epidemic by transforming the addiction’s physical trigger—the opioid pill—into an immediate lifeline for recovery. The campaign’s core proposition lies in offering accessible, personalized support precisely at the moment of highest vulnerability: when someone has a pill in their hand. By using the distinct imprint codes on common opioid pills as phone extensions, the helpline directly connects callers with individuals who have successfully quit the identical substance, enabling authentic peer-to-peer guidance and relatable advice.
Strategically, the campaign leverages a deep behavioral insight that moments of crisis can also be pivotal points for intervention. The targeting is highly contextual and situational, reaching users through location-specific out-of-home (OOH) advertising and complementary digital and social media channels to maximize relevance and immediacy of contact. This approach transforms typically overlooked pill packaging elements into a bridge toward help, making the helpline highly accessible and intuitive for those seeking assistance. The campaign further integrates collaboration with NGOs, activists, and healthcare experts to broaden impact and credibility while offering multiple avenues for public engagement, including advocacy, volunteering, and donation. By aligning creative messaging with both emotional immediacy and practical support, the campaign addresses not only individual recovery pathways but also broader societal involvement in combating opioid addiction. This multi-layered strategy blends social innovation with targeted outreach, positioning Anzen Health as both a practical resource and a catalyst for community-driven change in public health.
FORMAT#7 PRESENTER TESTIMONIAL — A person explains the product’s benefits directly to the audience. This campaign’s defining device is real users sharing personal stories with those seeking help via the helpline: each caller connects not to an actor or expert, but to someone who’s successfully quit the specific opioid they're struggling with. Although the campaign leverages context-specific OOH and documentary/social experiment undertones, its core solution is direct peer-to-peer testimonials—individuals personally explaining (and embodying) the path to recovery. The focus is not on dramatized narratives or symbolic storytelling, but authentic, first-hand experience and practical guidance delivered conversationally. This one-on-one, real-life testimony to the product's (the helpline’s) success is the architectural crux, thus aligning precisely with the Presenter Testimonial format. ADVERTISING FORMATS EXPLAINED: https://www.clapboard.com/blog/branding-and-advertising/brand-strategy/12-advertising-creative-formats
1. Hazelden Betty Ford Foundation – Positioned as a comprehensive addiction treatment leader, Hazelden Betty Ford emphasizes evidence-based clinical programs combined with family support and aftercare. They differentiate through extensive in-person and digital treatment options, integrating mental health with addiction recovery, serving as a trusted and historic institution in the US healthcare landscape.
2. Phoenix Healthcare / Phoenix Australia – Focused on research-driven public health initiatives, Phoenix combines healthcare delivery with innovative community engagement strategies. Their approach prioritizes harm reduction and culturally sensitive treatment programs, leveraging strong collaboration with NGOs and government bodies across multiple countries, including Australia and expanding influence in Canada and Germany.
3. Shatterproof – Shatterproof positions itself as a nonprofit dedicated to ending the opioid crisis through advocacy, education, and science-based treatment promotion. They uniquely leverage data-driven policy reform efforts and public awareness campaigns to improve treatment access and reduce stigma, partnering closely with healthcare providers and policymakers in the US market.
4. Canadian Centre on Substance Use and Addiction (CCSA) – CCSA stands out by integrating research, policy advice, and public health education to tackle addiction across Canada. They focus on providing evidence-based resources that shape national strategies, emphasizing innovation in prevention and support systems that engage public, private, and Indigenous community stakeholders.
5. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) – EMCDDA acts as the EU’s central hub for data and best practices on drug addiction and treatment. Their strategic angle centers on providing expert knowledge, policy recommendations, and fostering international cooperation among European countries, including Germany, to develop effective public health responses to opioid dependence.
Q: What is 855-How-To-Quit-(Opioids) (case study) about?
A: 855-How-To-Quit-(Opioids) (case study) is a 2024 campaign developed by Serviceplan and Serviceplan Germany for Anzen Health, launched across Canada, Germany, and the United States. The campaign introduces a helpline that leverages the imprint codes found on opioid pills as phone extensions, enabling individuals struggling with opioid addiction to connect directly with someone who has successfully quit that specific pill. By transforming the object of addiction into a point of intervention, the campaign delivers immediate, personalized support at the most critical moment and is supported by a coalition of NGOs, healthcare experts, and media partners.
Q: What creative device does 855-How-To-Quit-(Opioids) (case study) use?
A: According to Clapboard’s 12-format classification system, 855-How-To-Quit-(Opioids) (case study) employs FORMAT#7 PRESENTER TESTIMONIAL. The campaign’s defining creative device is direct peer-to-peer testimonials, where callers are connected not to actors or experts, but to real individuals who have overcome addiction to the same opioid pill. This approach prioritizes authentic, first-hand experience and practical guidance delivered conversationally, making the helpline’s support both relatable and credible. The campaign’s core is real-life testimony, aligning precisely with the Presenter Testimonial format as defined by Clapboard.
Q: What is the campaign proposition for 855-How-To-Quit-(Opioids) (case study)?
A: The strategic proposition of 855-How-To-Quit-(Opioids) (case study) is to provide accessible, personalized support to individuals at their most vulnerable—when they are holding an opioid pill. By using pill imprint codes as helpline extensions, Anzen Health positions itself as a practical and empathetic resource, directly connecting those in crisis with peers who have successfully quit the same substance. This approach reframes the moment of potential relapse as an opportunity for intervention, aiming to foster recovery through authentic connection and to mobilize broader societal engagement in combating opioid addiction.
Q: How does 855-How-To-Quit-(Opioids) (case study) rank in Clapboard's archive?
A: 855-How-To-Quit-(Opioids) (case study) holds a Clapboard Campaign Score of 82/100. This score reflects the campaign’s creative ambition, execution quality, and cultural relevance as evaluated by Clapboard’s global ad archive.
Q: Who are the competitors in Anzen Health's category?
A: In the healthcare and addiction recovery space, Anzen Health faces competition from several key players. Hazelden Betty Ford Foundation is recognized for its comprehensive, evidence-based clinical programs and integrated mental health support in the US. Phoenix Healthcare, including Phoenix Australia, is known for research-driven public health initiatives and culturally sensitive harm reduction programs across multiple countries. Shatterproof distinguishes itself through advocacy, education, and data-driven policy reform in the US opioid crisis. The Canadian Centre on Substance Use and Addiction (CCSA) leads with research and policy advice shaping national strategies in Canada, while the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) serves as the EU’s central authority on drug addiction data and policy collaboration, particularly in Germany.
.webp)
